Sveriges mest populära poddar
BiotechTV - News

Jefferies London: BeOne Medicines announced a phase 3 success for its HER2 bispecific today in gastric cancer. John Olyer walks us through that and the whole pipeline

10 min17 november 2025

He hit on earnings, the HER2, degraders, and what BeOne is looking for in potential partners.

BiotechTV - News med BiotechTV finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.